Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Omalizumab

2

X.h Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

2
Last update : 01/05/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Omalizumab-associated eosinophilic granulomatosis with polyangiitis: cause or coincidence?
BMJ case reports 2021 Jul 29;14; 2021 Jul 29
Churg-strauss syndrome: clinical symptoms, complementary investigations, prognosis and outcome, and treatment.
Seminars in respiratory and critical care medicine 2011 Jun;32;298-309 2011 Jun
[Churg-Strauss syndrome under omalizumab treatment: a rare visceral manifestation].
Journal de radiologie 2009 Nov;90;1737-9 2009 Nov
Churg-strauss syndrome in patients treated with omalizumab.
Chest 2009 Aug;136;507-518 2009 Aug
Development of Churg-Strauss syndrome with controlled asthma during omalizumab treatment.
The Journal of allergy and clinical immunology 2008 Jan;121;253-4 2008 Jan

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies